Libby Echo:Prio vs Tempus ECG-AF
AI Verdict
Choose Libby Echo:Prio if…
Choose Libby Echo:Prio if your clinical practice requires rapid, consistent, and automated analysis of echocardiograms for decision support and cardiac function quantification. This cloud-based platform is ideal for clinicians seeking an immediately available second opinion and low inter/intra-analyst variability in cardiac measurements, accessible remotely from any device.
View Libby Echo:Prio →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your facility aims to proactively identify patients aged 65 or older at increased risk of developing new-onset atrial fibrillation/flutter within the next 12 months, using existing 12-lead ECG recordings. This tool is best suited for supporting earlier identification and follow-up for at-risk geriatric patients without pre-existing AF, pacemakers, or ICDs.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Libby Echo:Prio | Tempus ECG-AF |
|---|---|---|
| Pricing | Custom | Contact vendor |
| Deployment | Cloud-based | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | No AI-estimated | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | No AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Libby Echo:PrioLibby Echo:Prio is a cloud-based platform offering remote access from any device and is designed to be embedded in existing clinical workflows, suggesting high flexibility and ease of use for clinicians in various settings. Tempus ECG-AF, while integrated into healthcare facility systems, explicitly states it does not have a dedicated user interface and relies on standard communication protocols with other medical systems, implying a less direct user interaction for the end-user.
Clinical Value
Tempus ECG-AFTempus ECG-AF offers a predictive risk assessment, identifying patients aged 65 or older at increased risk of developing atrial fibrillation within the next 12 months, which can lead to earlier identification and follow-up, potentially preventing serious events like AF-related strokes. Libby Echo:Prio provides decision support and automated measurements for echocardiogram analysis, enhancing efficiency and consistency in existing diagnostic workflows. While both are FDA-cleared and valuable, Tempus ECG-AF's proactive, predictive capability for a specific, high-impact condition offers a distinct and potentially higher clinical value.
Pricing & Value
Tempus ECG-AFTempus ECG-AF provides clear information regarding CMS reimbursement, including specific CPT codes and a Medicare rate, which is crucial for healthcare providers to assess the financial viability and value of the solution. In contrast, Libby Echo:Prio only states 'custom' pricing and requires contacting the vendor for details, lacking transparency in its cost structure.
Enterprise Readiness
Tempus ECG-AFTempus ECG-AF explicitly states it is HIPAA compliant and offers a Business Associate Agreement (BAA), which are non-negotiable requirements for healthcare enterprises handling protected health information. Libby Echo:Prio, however, states 'no' for both HIPAA compliance and BAA availability, making it unsuitable for most enterprise healthcare environments.
Innovation
Tempus ECG-AFTempus ECG-AF demonstrates a higher degree of innovation by utilizing AI for predictive risk assessment, identifying patients at risk of developing atrial fibrillation in the future, which enables proactive care strategies. Libby Echo:Prio, while innovative in applying AI to automate and standardize echocardiogram analysis, primarily enhances existing diagnostic processes rather than predicting future conditions.
Support & Docs
Tempus ECG-AFTempus ECG-AF provides explicit contact information for its Cardiology Support team, including an email address and a phone number, indicating a clear channel for technical assistance and inquiries. Information regarding specific support resources or documentation for Libby Echo:Prio was not readily available in the provided facts or web search results.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Libby Echo:Prio | Tempus ECG-AF |
|---|---|---|
| Product Name | Libby Echo:Prio | Tempus ECG-AF |
| Company | Dyad Medical | Tempus AI, Inc. |
| Primary Function | Cloud-based AI platform for fast, data-driven echocardiogram analysis, providing decision support and automated cardiac measurements for clinicians. | AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months. |
| Analyzed Data Type | Echocardiogram images | 12-lead ECG recordings |
| Target Patient Population | Not specified | Patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery. |
| Key Output/Benefit | Decision support for cardiac function quantification, automated estimation of cardiac measurements, consistent analysis, and low inter/intra-analyst variability. | Identifies patients at increased risk of developing Atrial Fibrillation/flutter (AF) within 12 months, supporting earlier identification and follow-up. |
Videos
Demos, reviews, and walkthroughs featuring Libby Echo:Prio and Tempus ECG-AF.